Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  >  CATEGORY RETURNS
CATEGORY RETURNS      
AMC : Category : Scheme :
ITI Pharma & Healthcare Fund-Reg(G)
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSun Pharmaceutical Industries Limited11.117414194524.6558
Domestic EquitiesDivi's Laboratories Limited9.00723117119.9759
Domestic EquitiesApollo Hospitals Enterprise Limited6.62461878414.6919
Domestic EquitiesMax Healthcare Institute Limited5.943912072113.1821
Domestic EquitiesTorrent Pharmaceuticals Limited5.16732644611.4598
Domestic EquitiesAurobindo Pharma Limited4.4495808589.8679
Domestic EquitiesFortis Healthcare Limited3.8477905248.5332
Domestic EquitiesLupin Limited3.7417360508.2983
Domestic EquitiesAlkem Laboratories Limited3.1667124537.0229
Domestic EquitiesAster DM Healthcare Limited3.16221071347.0130
Domestic EquitiesNeuland Laboratories Limited2.700646705.9893
Domestic EquitiesAbbott India Limited2.260918905.0142
Domestic EquitiesGlenmark Pharmaceuticals Limited2.0517212964.5503
Domestic EquitiesCohance Lifesciences Limited2.04431462714.5337
Domestic EquitiesLaurus Labs Limited2.0067413694.4505
Domestic EquitiesMankind Pharma Limited1.9792195294.3893
Domestic EquitiesDr. Reddy's Laboratories Limited1.8290315344.0562
Domestic EquitiesSai Life Sciences Limited1.7822395953.9526
Domestic EquitiesCipla Limited1.7503287923.8817
Domestic EquitiesIPCA Laboratories Limited1.5503224883.4382
Domestic EquitiesPark Medi World Limited1.44601660943.2068
Domestic EquitiesSBI Life Insurance Company Limited1.3623148303.0212
Domestic EquitiesBiocon Limited1.3306757062.9510
Domestic EquitiesLinde India Limited1.303342952.8905
Domestic EquitiesHealthcare Global Enterprises Limited1.2274472852.7220
Domestic EquitiesFDC Limited1.2251761792.7169
Domestic EquitiesSumitomo Chemical India Limited1.2190673942.7035
Domestic EquitiesPiramal Pharma Limited1.14761630122.5451
Domestic EquitiesRainbow Childrens Medicare Limited1.0809201502.3972
Domestic EquitiesGlaxoSmithKline Pharmaceuticals Limited1.068392132.3692
Domestic EquitiesOrchid Pharma Limited1.0132362582.2471
Domestic EquitiesOnesource Specialty Pharma Limited0.9995164592.2167
Domestic EquitiesShaily Engineering Plastics Limited0.9875112302.1900
Domestic EquitiesJubilant Ingrevia Limited0.9379355332.0801
Domestic EquitiesStandard Engineering Technology Ltd0.91891633572.0379
Domestic EquitiesCaplin Point Laboratories Limited0.8010104491.7764
Domestic EquitiesShilpa Medicare Limited0.7524495681.6687
Domestic EquitiesAstraZeneca Pharma India Limited0.750118801.6636
Domestic EquitiesSupriya Lifescience Limited0.7493253701.6617
Domestic EquitiesZydus Lifesciences Limited0.6979167921.5477
Domestic EquitiesPoly Medicure Limited0.6821120441.5128
Domestic EquitiesSyngene International Limited0.3267171590.7245
Total 98.2103 217.8074
Cash & Cash Equivalents and Net AssetsTREPS 02-Mar-20261.0550 2.3397
Cash & Cash Equivalents and Net AssetsNet Receivables / (Payables)0.7347 1.6295
Total 1.7897 3.9692
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.